Sun Pharmaceutical Industries Ltd (SUN.BO)

SUN.BO on Bombay Stock Exchange

915.95INR
30 Jan 2015
Change (% chg)

Rs-3.25 (-0.35%)
Prev Close
Rs919.20
Open
Rs920.15
Day's High
Rs927.35
Day's Low
Rs909.20
Volume
109,336
Avg. Vol
201,855
52-wk High
Rs939.05
52-wk Low
Rs552.50

SUN.BO

Chart for SUN.BO

About

Sun Pharmaceutical Industries Limited is an international specialty pharma company. The Company manufactures and markets pharmaceutical formulations as branded generics, as well as generics in India, the United states and several other markets across the world. The Company’s business is divided into four segments: US Generics,... (more)

Overall

Beta: 0.61
Market Cap(Mil.): Rs1,900,811.00
Shares Outstanding(Mil.): 2,071.16
Dividend: 1.50
Yield (%): 0.16

Financials

  SUN.BO Industry Sector
P/E (TTM): 31.57 39.97 40.64
EPS (TTM): 29.07 -- --
ROI: 32.12 18.85 18.12
ROE: 31.49 19.60 18.97
Search Stocks

Deals of the day- Mergers and acquisitions

Jan 30 - The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Friday:

2:27am IST

Sun Pharmaceutical wins U.S. approval to buy Ranbaxy

WASHINGTON - India's Sun Pharmaceutical Industries Ltd has won U.S. approval to buy Ranbaxy Laboratories Ltd on condition that it sell its interest in a generic antibacterial medicine, the U.S. Federal Trade Commission said on Friday.

1:02am IST

Sun Pharmaceutical wins U.S. approval to buy Ranbaxy

WASHINGTON - India's Sun Pharmaceutical Industries Ltd has won U.S. approval to buy Ranbaxy Laboratories Ltd on condition that it sell its interest in a generic antibacterial medicine, the U.S. Federal Trade Commission said on Friday.

1:00am IST

UPDATE 1-Sun Pharmaceutical wins U.S. approval to buy Ranbaxy

WASHINGTON, Jan 30 - India's Sun Pharmaceutical Industries Ltd has won U.S. approval to buy Ranbaxy Laboratories Ltd on condition that it sell its interest in a generic antibacterial medicine, the U.S. Federal Trade Commission said on Friday.

12:49am IST

Sun Pharmaceutical wins U.S. approval to buy Ranbaxy

WASHINGTON, Jan 30 - Sun Pharmaceutical Industries Ltd has won U.S. approval to buy Ranbaxy Laboratories Ltd on condition that it sells its interest in a generic anti-bacterial medicine, the Federal Trade Commission said on Friday.

12:00am IST

BUZZ-JPMorgan upgrades India's Sun Pharma to "overweight"

** JPMorgan upgrades Sun Pharmaceutical Industries Ltd to "overweight" from "neutral"

06 Jan 2015

REFILE-BUZZ-Indian shares to be governed by global events in near term - Credit Suisse

(Corrects spelling of Thomson Reuters Datastream in second bullet point) ** Since expansion in P/E multiples drove 3/5th of India's market performance in 2014, questions arise over whether rally is sustainable this year - Credit Suisse ** MSCI India index 1-yr forward P/E expands to 17.2 vs 14.6 at the start of 2014 - Thomson Reuters Datastream ** India's NSE index rose 31.4 pct in 2014, making it best performing market in Asia after China ** Global linkages to drive market, ap

05 Jan 2015

Indian FX/debt factors to watch - Dec 9

GLOBAL MARKETS ROUNDUP * Asian share markets were mostly in the red on Tuesday while the U.S. dollar began to edge higher once again aided by a media report the Federal Reserve might take a rhetorical step toward tightening at its meeting next week. * The yen held onto sizeable gains early on Tuesday, having staged a broad short-covering rally as a big drop in oil prices hit global risk appetite. Both the dollar and euro fell from multi-year peaks with the greenback sliding to 120.

09 Dec 2014

Deals of the day- Mergers and acquisitions

(Adds Mizuho, Oriola-KD, Sharp, Vattenfall, TriMas Corp, Abris Capital)

09 Dec 2014

CORRECTED-Deals of the day- Mergers and acquisitions

(Removes erroneous reference to Canadian Solar in Sharp Corp item)

09 Dec 2014

Earnings vs. Estimates

Search Stocks